Richard J Wallace has joined the Bridgehead Board as a Non-Executive Director, following 15 years at GlaxoSmithKline (GSK), where he was most recently Senior Vice President of Global Product Strategy, accountable for Global Health Outcomes, Scientific Communications, Global Commercial Strategy and Business & Commercial Analysis. He also served as a member of its Research and Development Executive, Commercial Operations Committee, Product Management Board and Scientific Advisory Board. During his years at GSK and its heritage companies, Richard held positions from Vice President Commercial (Canadian Pharmaceuticals), Vice President U.S. Business Development, Vice President Sales & Marketing (U.S. Oncology and HIV), Vice President Clinical Development and Product Strategy, and Vice President of Global Commercial Strategy.
His experience prior to joining GSK included eight years with Bristol-Myers Squibb and seven years at Johnson & Johnson in assignments from Marketing, Sales, Manufacturing and General Management.
Richard received BCom and BCom(Hons) degrees from Rhodes University, South Africa and currently serves on the board of directors of Avigen Inc, ImmunoGen Inc and Clinical Data Inc.
Bridgehead International CEO, Timothy Fitzgerald commented: "We are delighted at Richard's decision to join the team at a time when we are pushing ahead with a major expansion of our activities in North America. His senior level experience, particularly in market access and health outcomes fields, will be of real value to Bridgehead and its clients."
Over the past four years Bridgehead's Market Access business has grown to be the single largest practice area in the company.
About Bridgehead International
Bridgehead International is a leading biopharmaceutical consultancy group, offering a range of services designed to assist clients in achieving extraordinary growth across the product and technology value chain, through three practice areas:
With over 50 consultants and associates in Europe, North America and Asia, Bridgehead Consulting provides a powerful combination of strategic, scientific, medical, technical, commercial, economic, decision support, modelling and intellectual property skills and experience.
